Tumor Necrosis Factor-α -308 Gene Polymorphism is Associated with Synthetic Hemodialysis Graft Failure
Authors:
- Kristen BassKBKristen Bass
- 1 February 2003
- journal article
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 51 (1) , 19-26
Abstract
Background: Progressive venous stenosis mediated, in part, by inflammatory cytokines is a major cause of synthetic hemodialysis graft failure. A tumor necrosis factor-α (TNF-α) gene polymorphism (G to A, position -308) has been shown to increase plasma cytokine levels and severity of diseases with an underlying inflammatory component. Methods: We genotyped 67 patients with synthetic polytetrafluoroethylene (PTFE) grafts and examined the association of the high- (AA or GA) and low- (GG) production TNF-α -308 genotypes with the rate of graft failures/thrombosis and graft survival. Results: Hemodialysis patients with the high-production TNF-α genotypes had a significantly increased rate of PTFE graft failure at 90 days (37.2% versus 14%) and 1 year (62.8% versus 34.4%) after graft placement compared with patients with the low-production genotype (respectively). Hemodialysis patients with the high-production TNF-α genotypes had significantly lower cumulative PTFE graft survival at 1 year (29.4% ± 11.1% versus 71.2 ± 6.8%) and 2 years (22.1% ± 10.5% versus 48.2 ± 8.1%) compared with patients with the low-production genotype (respectively). Patients with the A allele had approximately twice the mean thrombosis rate compared with those who had the low-production TNF-α genotype (3.3 ± 0.8 versus 1.7 ± 0.4 thromboses/patient/year, respectively; mean ± SEM, p < .05). Conclusions: These data suggest that the TNF-α -308 A allele is associated with increased PTFE graft thrombosis and failure in hemodialysis patients.Keywords
This publication has 44 references indexed in Scilit:
- Cytokine gene polymorphism in human disease: on-line databases, Supplement 2Genes & Immunity, 2002
- Venous neointimal hyperplasia in polytetrafluoroethylene dialysis graftsKidney International, 2001
- Natural history of arteriovenous grafts in hemodialysis patientsAmerican Journal of Kidney Diseases, 2000
- Differential Regulation of Vascular Smooth Muscle Nuclear Factor kappa-B by G α q-coupled and Cytokine ReceptorsJournal of Molecular and Cellular Cardiology, 2000
- Expression of CCR2 by Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Cytokine gene polymorphisms predict acute graft rejection following renal transplantationKidney International, 1999
- Pentoxifylline Inhibits PDGF-induced Proliferation of and TGF-β-stimulated Collagen Synthesis by Vascular Smooth Muscle CellsJournal of Molecular and Cellular Cardiology, 1999
- Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical reportTransplant Immunology, 1998
- Formation of myointimal hyperplasia and cytokine production in experimental vein graftsSurgery, 1998
- Platelet-derived growth factor is a cofactor in the induction of 1α(I) procollagen expression by transforming growth factor β1 in smooth muscle cellsJournal of Vascular Surgery, 1996